PACS Group: Quality-Fueled Momentum Fuels Another Guidance Raise

PACS Group delivered a second quarter that underscores the durability of its locally led, centrally supported operating model. Revenue grew 9.1% year-over-year to $1.43 billion, while adjusted EBITDA jumped 25% to $166.8 million—a gap that reflects meaningful margin expansion as facilities mature. The company raised full-year revenue guidance to $5.75–5.85 billion and adjusted EBITDA to $640–660 million, a $100 million and $35 million increase on both ends, respectively. The story is not about one-off gains; it is about occupancy increased across the portfolio, with same-store occupancy up 150 basis points and overall skilled mix improving 100 basis points.

A Model That Compounds

The quarter's performance was driven by the existing portfolio, not just acquisitions. Same-store revenue rose 5.8%, and the company now operates 324 facilities across 17 states, with 35,631 beds. The maturation of the 2024 acquisition cohort is paying off: the skilled nursing portfolio now includes 184 mature, 100 ramping, and 6 new facilities. Ramping facilities, in particular, stood out—occupancy and skilled mix both improved notably, a point CEO Jason Murray emphasized: “This is a cohort we're incredibly proud of. Obviously, the numbers have increased in this cohort.” — Joshua Jergensen, President and Chief Operating Officer · 2026-08-05 The embedded potential is significant, as these facilities still trail mature ones by roughly 600 basis points of occupancy.

Financially, the operating leverage is visible. Operating margin expanded to 8.5% in the quarter, up 470 basis points year-over-year, while free cash flow margin reached 15.2%. The company also introduced adjusted net income and adjusted EPS, which grew 29.6% and 34% respectively, to $0.63 per share. Operating margin reached 8.5%, a 4.7pp year-over-year gain, as revenue growth outpaced expense growth.

Quality: The Moat That Drives Payer Leverage

Management is adamant that clinical quality is not a separate virtue but the engine of financial performance. With 83.6% of skilled nursing facilities rated 4 or 5 stars by CMS, and mature facilities averaging 4.5 stars versus the industry's 3.7, PACS is using that track record to negotiate better payer contracts. Jason Murray put it plainly:

It is incredibly important. I think the way that we talk about quality is that it is the fundamental basis behind our entire business thesis... we want to have a seat at the table when we are looking at different payer contracts.

The payer conversations are also benefiting from density and a favorable rate environment. Medicaid rates rose 3% in the quarter, and management expects continued growth. Managed care contracts are being renegotiated at higher rates as facilities demonstrate quality and bed availability. As Josh Jergensen noted, “we've been very active in ensuring that we get in front of the individuals at the state level... we are the lowest-cost institutional setting for people to receive care.” — Joshua Jergensen, President and Chief Operating Officer · 2026-08-05

AI and M&A: Levers for the Back Half

On the innovation front, PACS is cautiously integrating AI to improve clinical documentation and patient intake, freeing up clinicians for direct care. Josh Jergensen said: “There are certainly really good use cases for AI... we've seen some good use cases where it's doing exactly what you mentioned.” — Joshua Jergensen, President and Chief Operating Officer · 2026-08-05 This aligns with the broader healthcare trend of using data to reduce administrative burden.

The acquisition engine is also reigniting. The pending Eduro deal—34 facilities, with 20 closed on August 1—adds density in Texas and adjacent states. The company is targeting high-quality assets with room to improve occupancy and skilled mix, as Carey Hendrickson explained: “We feel very good about the momentum in our business. But we do want to be disciplined in our guide.” — Carey Hendrickson, Chief Financial Officer · 2026-08-05 The updated guidance only includes a modest contribution from the 20 closed facilities, leaving upside from the remaining 14 and other deals expected to close by year-end.

Investors should also note the balance sheet: net leverage is just 0.1x, and liquidity stands at $756.6 million, providing ample firepower. The stock has rallied 31% in the last 90 days, though it sits 8.7% below its August peak. With the remediation of material weaknesses progressing and a clear path to organic growth, the existing portfolio remains the primary earnings driver, supported by ramping facility improvements that are just beginning to translate into margins.